Display options
Cite
Xirouchaki CE, Jia Y, McGrath MJ, et al. Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Sci Adv. 2021;7(51):eabl4988doi: 10.1126/sciadv.abl4988.
Xirouchaki, C. E., Jia, Y., McGrath, M. J., Greatorex, S., Tran, M., Merry, T. L., Hong, D., Eramo, M. J., Broome, S. C., Woodhead, J. S. T., D'souza, R. F., Gallagher, J., Salimova, E., Huang, C., Schittenhelm, R. B., Sadoshima, J., Watt, M. J., Mitchell, C. A., & Tiganis, T. (2021). Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Science advances, 7(51), eabl4988. https://doi.org/10.1126/sciadv.abl4988
Xirouchaki, Chrysovalantou E, et al. "Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance." Science advances vol. 7,51 (2021): eabl4988. doi: https://doi.org/10.1126/sciadv.abl4988
Xirouchaki CE, Jia Y, McGrath MJ, Greatorex S, Tran M, Merry TL, Hong D, Eramo MJ, Broome SC, Woodhead JST, D'souza RF, Gallagher J, Salimova E, Huang C, Schittenhelm RB, Sadoshima J, Watt MJ, Mitchell CA, Tiganis T. Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Sci Adv. 2021 Dec 17;7(51):eabl4988. doi: 10.1126/sciadv.abl4988. Epub 2021 Dec 15. PMID: 34910515; PMCID: PMC8673768.
Copy Download .nbib Format: NLM
Share it on

Sci Adv. 2021 Dec 17;7(51):eabl4988. doi: 10.1126/sciadv.abl4988. Epub 2021 Dec 15.

Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance.

Science advances

Chrysovalantou E Xirouchaki, Yaoyao Jia, Meagan J McGrath, Spencer Greatorex, Melanie Tran, Troy L Merry, Dawn Hong, Matthew J Eramo, Sophie C Broome, Jonathan S T Woodhead, Randall F D'souza, Jenny Gallagher, Ekaterina Salimova, Cheng Huang, Ralf B Schittenhelm, Junichi Sadoshima, Matthew J Watt, Christina A Mitchell, Tony Tiganis

Affiliations

  1. Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
  2. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.
  3. Discipline of Nutrition, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  4. Monash Biomedical Imaging, Monash University, Clayton, Victoria 3800, Australia.
  5. Monash Proteomics and Metabolomics Facility, Monash University, Clayton, Victoria 3800, Australia.
  6. Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  7. Department of Physiology, Monash University, Clayton, Victoria 3800, Australia.
  8. Monash Metabolic Phenotyping Facility, Monash University, Clayton, Victoria 3800, Australia.

PMID: 34910515 PMCID: PMC8673768 DOI: 10.1126/sciadv.abl4988

Abstract

[Figure: see text].

References

  1. Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383 - PubMed
  2. BMC Med Genet. 2008 Apr 21;9:30 - PubMed
  3. Sci Adv. 2021 Feb 26;7(9): - PubMed
  4. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15565-70 - PubMed
  5. Proteomics. 2014 May;14(9):1006-0 - PubMed
  6. Endocr Connect. 2015 Mar;4(1):R1-R15 - PubMed
  7. Nat Commun. 2019 Oct 11;10(1):4623 - PubMed
  8. Proc Natl Acad Sci U S A. 2009 May 26;106(21):8665-70 - PubMed
  9. Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7815-20 - PubMed
  10. Hypertension. 2015 Mar;65(3):547-53 - PubMed
  11. J Biol Chem. 2004 Aug 13;279(33):34682-90 - PubMed
  12. Cell. 2020 Mar 5;180(5):968-983.e24 - PubMed
  13. Cell Metab. 2014 Jul 1;20(1):85-102 - PubMed
  14. Endocrinology. 2016 Aug;157(8):3009-15 - PubMed
  15. J Clin Invest. 2004 Dec;114(12):1752-61 - PubMed
  16. Circ Res. 2010 Apr 16;106(7):1253-64 - PubMed
  17. Mol Cell. 1998 Nov;2(5):559-69 - PubMed
  18. Diabetes. 2002 Oct;51(10):2944-50 - PubMed
  19. Physiol Rev. 2008 Oct;88(4):1243-76 - PubMed
  20. Sci Rep. 2017 Oct 10;7(1):12902 - PubMed
  21. Am J Physiol Endocrinol Metab. 2011 May;300(5):E761-70 - PubMed
  22. Nat Commun. 2016 Mar 15;7:10894 - PubMed
  23. Antioxid Redox Signal. 2010 Oct 1;13(7):1011-22 - PubMed
  24. Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17787-92 - PubMed
  25. Cell Metab. 2013 Feb 5;17(2):162-84 - PubMed
  26. Mol Cell Biol. 2016 May 16;36(11):1655-72 - PubMed
  27. Elife. 2018 Feb 06;7: - PubMed
  28. Diabetologia. 2012 Feb;55(2):468-78 - PubMed
  29. Redox Biol. 2016 Dec;10:191-199 - PubMed
  30. Skelet Muscle. 2012 May 07;2(1):8 - PubMed
  31. Physiol Rev. 2007 Jan;87(1):245-313 - PubMed
  32. Elife. 2018 Dec 27;7: - PubMed
  33. J Physiol. 2007 May 15;581(Pt 1):309-18 - PubMed
  34. Mol Metab. 2021 Mar;45:101160 - PubMed
  35. Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E157-67 - PubMed
  36. J Appl Physiol (1985). 2009 Oct;107(4):1028-36 - PubMed
  37. J Physiol. 2016 Sep 15;594(18):5195-207 - PubMed
  38. Free Radic Biol Med. 2011 Jun 15;50(12):1749-59 - PubMed
  39. Antioxid Redox Signal. 2013 Feb 20;18(6):603-21 - PubMed
  40. Cell Metab. 2009 Oct;10(4):260-72 - PubMed
  41. Diabetes. 2017 Aug;66(8):2072-2081 - PubMed
  42. Nature. 2006 Apr 13;440(7086):944-8 - PubMed
  43. Free Radic Res. 2014 Jan;48(1):12-29 - PubMed
  44. PLoS One. 2014 May 29;9(5):e96378 - PubMed
  45. Cell. 2014 Nov 6;159(4):738-49 - PubMed
  46. Physiol Rep. 2019 Feb;7(3):e13998 - PubMed
  47. Am J Clin Nutr. 2008 Jan;87(1):142-9 - PubMed
  48. Trends Pharmacol Sci. 2011 Feb;32(2):82-9 - PubMed
  49. Curr Opin Toxicol. 2016 Dec;1:80-91 - PubMed
  50. J Physiol. 2016 Sep 1;594(17):4997-5008 - PubMed
  51. Cell. 2006 Oct 20;127(2):397-408 - PubMed
  52. Diabetes. 2018 Jul;67(7):1246-1257 - PubMed
  53. Cell Metab. 2017 Aug 1;26(2):375-393.e7 - PubMed
  54. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2931-6 - PubMed
  55. J Clin Invest. 2009 Mar;119(3):573-81 - PubMed
  56. Cell Signal. 2006 Jan;18(1):69-82 - PubMed
  57. Cell Metab. 2016 Jun 14;23(6):1034-1047 - PubMed
  58. Free Radic Biol Med. 2016 Sep;98:123-130 - PubMed
  59. FASEB J. 2019 Jul;33(7):8022-8032 - PubMed

Publication Types